VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
0.1569
-0.0141 (-8.25%)
At close: Oct 16, 2026, 4:00 PM EDT
0.1599
+0.0030 (1.91%)
After-hours: Oct 16, 2026, 7:57 PM EDT
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of $2.6 million as of October 16, 2026. It is the 46,956th most valuable company in the world and the 6,300th biggest in the United States. Its market cap has decreased by 38.05% in one year.
Market Cap
2.60M
Enterprise Value
1.25M
1-Year Change
-38.05%
Global Rank
Country Rank
#6,300 United States
Category
ChartMarket Cap Chart
Since April 17, 2025, VivoSim Labs's market cap has increased from $2.52M to $2.60M, an increase of 3.38%. That is a compound annual growth rate of 2.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 822.07K | -68.97% |
| Dec 31, 2025 | 2.65M | 5.23% |
| Apr 17, 2025 | 2.52M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.02M |
| 60 Degrees Pharmaceuticals | 3.01M |
| Eocene | 2.97M |
| Addex Therapeutics | 2.97M |
| Aptevo Therapeutics | 2.92M |
| Mustang Bio | 2.85M |
| HCW Biologics | 2.77M |
| Clearmind Medicine | 2.63M |